Effects of 6-hydroxydopamine upon primary and secondary thymus dependent immune responses.
Hall. N R NR; McClure. J E JE; Hu. S K SK; Tare. N S NS; Seals. C M CM; Goldstein. A L AL
Key Findings
- 6‑OHDA reduced primary antibody titers to sheep red blood cells
- Serum thymosin‑alpha‑1 rose by day 3 after 6‑OHDA and normalized by day 5
- Thymocyte TdT activity showed an early drop then a later increase
Practical Outcomes
- The results suggest that acute stressors can temporarily boost thymosin‑alpha‑1 levels, but the effect is short‑lived and linked to immune suppression. For biohackers, there’s no clear protocol or dosage to apply, and the findings don’t support using 6‑OHDA or similar stressors to enhance thymosin‑alpha‑1 benefits.
Summary
In mice, a chemical called 6‑hydroxydopamine lowered the first‑time antibody response to a foreign protein and caused a short‑term rise in the natural immune peptide thymosin‑alpha‑1, which went back to normal after a few days. The study mainly explores how stress hormones affect immunity, not how to use thymosin‑alpha‑1 as a supplement.
Abstract
Adult male mice were treated with various doses of 6-hydroxydopamine in order to assess the effects of this drug upon thymic dependent immunity. A consistent decrease in primary antibody titers to sheep erythrocytes was observed following treatment with this drug. Serum levels of thymosin alpha 1 were increased by day three after 6-OHDA with a return to normal by day five. Thymocyte terminal deoxynucleotidyl transferase changes were biphasic with an initial decrease after 6-OHDA followed by an increase. Changes in mitogen responsiveness were observed but were not consistently reproducible. Involvement of both catecholamines and corticosteroids in bringing about these observed changes was discussed.
Study Information
pubmed
1982
1982-10-01T00:00:00.000Z
10.1016/0162-3109(82)90035-2
69
20